Skip to content
GRAPHORA
Menu

PUBLIC COMPANY OVERVIEW · AI-enabled drug development

Olivo Sciences

Olivo Sciences applies AI and multimodal data to precision drug development for brain disorders.

What the company does

The company describes working with de-identified clinical, imaging, multi-omics and wearable data. Its stated applications span discovery, trial design, enrollment and post-marketing work. The focus is not one isolated model: it is connecting different kinds of evidence to the decisions made throughout a drug-development program. Data quality, scientific validation and clinical relevance remain important questions when assessing this category.

Areas to understand

These themes describe the company’s public focus, not a personalized fit rating. Members bring their own experience, interests and questions to the review process.

Where it fits on Graphora

This company is presented within Healthcare. Explore that strategy to see related public overviews, then use your Graphora membership to review available opportunity details.

Selected fund portfolios

Portfolio selection is separate from a completed investment. Fund and company applications are independent.

MAKE IT PERSONAL

Explore Olivo Sciences as a member.

Create your Graphora profile or sign in to review available opportunity information. Confidential materials stay protected. Access and investment participation depend on the applicable requirements, not membership alone.

Join / Sign in to explore ↗